金沙娱城手机app下载

Providing innovative and affordable medicines
for all patients

We have a proven track record of initiating strategic commercialisation collaborations with global leading pharmaceutical companies in advance of product approvals, which we believe will enable us to expeditiously capture global market share through the established capabilities and resources of our partners. To this end, we have entered into license and commercialisation agreements with multiple partners, including Accord, Cipla, Biosidus, Jacobson Medical and KG Bio. We have entered into agreements for the licensing and commercialisation in over 92 countries and regions.

Contact us: BD@henlius.com

Collaborators
展望未来,复宏汉霖人将始终以“持续创新,卓越运营;以优质生物药,造福全球病患”为使命,不断探索发展,专注提供质高价优的生物药,为成全球最受景仰的创新型生物医药公司而不懈努力。
Baidu
sogou